Blue Arrow Capital Management’s Medtronic MDT Stock Holding History

Blue Arrow Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-85,000	Closed	-$6.63M	–	165
2015 Q1	$6.63M	Buy	85,000 +81,879	+2,623%	+$6.21M	0.65%	45
2014 Q4	$225K	Sell	3,121 -22,167	-88%	-$1.54M	0.03%	171
2014 Q3	$1.57M	Buy	+25,288	New	+$1.61M	0.17%	130

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Blue Arrow Capital Management's MDT Position: Q2 2015 in Review

Blue Arrow Capital Management sold out of Medtronic (MDT) in Q2 2015, closing a stake of 85,000 shares — an estimated $6.63M sold.

Blue Arrow Capital Management first reported a position in MDT in Q3 2014 and held it in 3 quarters. The position peaked at $6.63M in Q1 2015. 1,261 funds tracked by Wall St. Rank hold MDT as of Q2 2015.

Blue Arrow Capital Management reported no remaining Medtronic position as of Q2 2015 after selling out during the quarter.
Blue Arrow Capital Management sold 85,000 Medtronic shares in Q2 2015, an estimated $6.63M.
Blue Arrow Capital Management first reported a position in Medtronic in Q3 2014 and held it in 3 quarters.
Blue Arrow Capital Management's Medtronic position peaked at $6.63M in Q1 2015.
1,261 funds tracked by Wall St. Rank held Medtronic as of Q2 2015.

Based on Blue Arrow Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.